ACADEMIA
TMDU, Takeda Running Joint Research on Heteroduplex Oligonucleotide for Neuro Diseases
Tokyo Medical and Dental University (TMDU) and Takeda Pharmaceutical revealed on August 20 that they are conducting joint research on heteroduplex oligonucleotide (HDO) drugs for the treatment of intractable neurological diseases. They initiated this collaboration in December 2017 but have…
To read the full story
ACADEMIA
- Japan’s Maternal RSV Vaccine Uptake at 11.6%, Survey Finds
January 15, 2026
- Early CGP Testing Cuts Mortality Risk by 41%, Research Shows
December 1, 2025
- 5-Year Cancer Survival Shows Wide Gap by Tumor Types, Gains Seen in Lymphoma: NCC
November 20, 2025
- Japan Sleep Society to Revise Insomnia Guidelines to Reflect Orexin Antagonists
October 8, 2025
- Japan’s Sakaguchi Wins 2025 Nobel Prize in Medicine
October 7, 2025
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…





